| Type 1 Diabetes Mellitus |
1 |
1 |
| Liver |
0 |
0.5 |
| Fatty Liver |
0 |
0.49 |
| Liver Disease |
0 |
0.49 |
| Aminotransferase |
0 |
0.42 |
| Biliary Disease |
0 |
0.31 |
| Cardiovascular Risk Management |
0 |
0.31 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.31 |
| Cardiovascular disease |
0 |
0.3 |
| Kidney |
0 |
0.3 |
| Sleep |
0 |
0.3 |
| Obstructive Sleep Apnea |
0 |
0.28 |
| Heart Failure (HF) |
0 |
0.22 |
| Heart |
0 |
0.2 |
| Metabolism |
0 |
0.2 |
| Orbit |
0 |
0.2 |
| Platelet Count |
0 |
0.17 |
| Cardiovascular Imaging |
0 |
0.16 |
| Renal Failure |
0 |
0.15 |
| Hemoglobin A1c |
0 |
0.14 |
| Sleep Apnea |
0 |
0.14 |
| Sleep Disorders |
0 |
0.14 |
| Continuous Glucose Monitoring |
0 |
0.13 |
| Amputation |
0 |
0.1 |
| California |
0 |
0.1 |
| Canada |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Echocardiography |
0 |
0.1 |
| Epidemiology |
0 |
0.1 |
| Exercise |
0 |
0.1 |
| Femoral |
0 |
0.1 |
| Hemoglobin |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Hypoglycemia |
0 |
0.1 |
| Infarction |
0 |
0.1 |
| Insulin Pump |
0 |
0.1 |
| Insulin Therapy |
0 |
0.1 |
| Interprofessional Continuing Education |
0 |
0.1 |
| Jobs |
0 |
0.1 |
| Massachusetts |
0 |
0.1 |
| Memory |
0 |
0.1 |
| Nerve |
0 |
0.1 |
| Pancreas |
0 |
0.1 |
| Preventive Screening |
0 |
0.1 |
| Retinopathy |
0 |
0.1 |
| Tissue Doppler Imaging |
0 |
0.1 |